Skip to main content

Brian Dolan

By Brian Dolan | 08:49 am | August 27, 2014
As it does every year, analyst firm Gartner updated its famous Hype Cycle for Emerging Technologies this summer and, according to the firm, "mobile health monitoring" is approaching the bottom of the so-called "trough of disillusionment".
By Brian Dolan | 10:23 am | August 26, 2014
Blue Cross Blue Shield of Massachusetts has added a mobile and online offering, called OneHealth, to bolster its mental health and behavioral health programs.
By Brian Dolan | 09:59 am | August 26, 2014
San Antonio-based AirStrip has raised $25 million in strategic funding led by new investor the Gary and Mary West Health Investment Fund, Sequoia Capital and Wellcome Trust with participation from other existing investors HCA and Qualcomm.
By Brian Dolan | 09:29 am | August 25, 2014
Fresh off its $2.
By Brian Dolan | 08:39 am | August 25, 2014
Last week MobiHealthNews broke the news that Aetna had decided to shutdown its high-profile, health tracking and data aggregation platform CarePass by the end of the year.
By Brian Dolan | 05:04 am | August 20, 2014
Norwalk, Connecticut-based medication adherence platform company HealthPrize has raised $3 million in a new round of funding led by Mansa Capital to help it expand globally.
By Brian Dolan | 11:32 am | August 07, 2014
Last month iMedicalApps' Dr.
By Brian Dolan | 09:17 am | August 07, 2014
Earlier this year Pew Research's Internet Project published a report called Digital Living 2025, which surveyed and aggregated ideas and predictions from internet scholars and successful entrepreneurs on the impact technology will have on our daily lives a decade from now.
By Brian Dolan | 11:25 am | August 06, 2014
During its quarterly call with investors this week WebMD teased a small acquisition it made last month, released some mobile adoption numbers, and discussed its recently launched health tracking offering.
By Brian Dolan | 07:54 am | August 01, 2014
Kinsa's smartphone-connected thermometer The US Food and Drug Administration has proposed to largely deregulate a sizable list of Class II and Class I medical devices and no longer require their makers to go through the 510(k) process.